Single nucleotide polymorphisms diagnostic for schizophrenia

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61P 25/18 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2441353

The invention provides nucleic acid segments of the human G protein coupled receptor Con-202 gene including polymorphic sites. Allele specific primers and probes hybridizing to regions flanking these sites are also provided. The invention also provides methods for determining the genetic risk of developing schizophrenia or diagnosing schizophrenia.

L'invention porte sur des segments d'acide nucléique du gène humain Con-202 du récepteur couplé à la protéine G comprenant des sites polymorphiques. L'invention porte également sur des amorces spécifiques d'allèle et sur des sondes s'hybridant aux régions bordant ces sites, ainsi que sur des procédés de détermination du risque génétique à développer ou diagnostiquer la schizophrénie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Single nucleotide polymorphisms diagnostic for schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Single nucleotide polymorphisms diagnostic for schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single nucleotide polymorphisms diagnostic for schizophrenia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1494349

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.